| # | Drug | Count |
|---|---|---|
| 0 | FLUDARABINE PHOSPHATE | 8 |
| 1 | CYCLOPHOSPHAMIDE | 6 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 6 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 6 |
| 4 | BLINATUMOMAB | 5 |
| 5 | RUXOLITINIB | 5 |
| 6 | ACYCLOVIR | 4 |
| 7 | INOTUZUMAB OZOGAMICIN | 4 |
| 8 | SULFAMETHOXAZOLE AND TRIMETHOPRIM | 4 |
| 9 | INEBILIZUMAB | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INOTUZUMAB OZOGAMICIN | 4 | 0.0013 |
| 1 | TREOSULFAN | 2 | 0.0007 |
| 2 | BLINATUMOMAB | 5 | 0.0005 |
| 3 | CLINDAMYCIN PHOSPHATE | 2 | 0.0004 |
| 4 | MICAFUNGIN SODIUM | 2 | 0.0003 |
| 5 | CLINDAMYCIN HYDROCHLORIDE | 1 | 0.0003 |
| 6 | THIOTEPA | 2 | 0.0002 |
| 7 | FLUDARABINE PHOSPHATE | 8 | 0.0002 |
| 8 | MITOXANTRONE HYDROCHLORIDE | 1 | 0.0002 |
| 9 | TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD19-directed Cytolytic Antibody [EPC] | 3 | 0.0035 |
| 1 | CD22-directed Immunoconjugate [EPC] | 4 | 0.0013 |
| 2 | Echinocandin Antifungal [EPC] | 2 | 0.0002 |
| 3 | Vitamin K [EPC] | 1 | 0.0001 |
| 4 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 5 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 6 | Thrombopoietin Receptor Agonist [EPC] | 1 | 0.0001 |
| 7 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 8 | Bile Acid [EPC] | 1 | 0.0000 |
| 9 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 4 | 0.0000 |